Boehringer and MD Anderson extend KRAS cancer collaboration
Amgen, Boehringer Ingelheim, cancer, KRAS, lung cancer, MD Anderson, Mirati
0 Comment
MD Anderson
Bayer and MD Anderson collaborate on novel targeted cancer treatments
Bayer, cancer partnership, cancer research, Innovation, MD Anderson, novel targeted cancer treatments
0 Comment
Bayer and the University of Texas MD Anderson Cancer Center have signed a five-year collaboration agreement to accelerate the development of novel targeted treatments for cancer.
